Post-ERCP pancreatitis (PEP) is the most common serious adverse event attributed to the
procedure, resulting in annual estimated costs exceeding 150 million dollars in the United …

This is one of a series of statements discussing the use of GI endoscopy in common clinical
situations. The Standards of Practice Committee of the American Society for Gastrointestinal …

This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy
(ESGE). It addresses the prophylaxis of post-endoscopic retrograde …

Endoscopic retrograde cholangiopancreatography (ERCP) is a well-known procedure with
both diagnostic and therapeutic utilities in managing pancreaticobiliary conditions. With the …

Background Rectal indometacin decreases the occurrence of pancreatitis after endoscopic
retrograde cholangiopancreatography (ERCP). However, the population most at risk and the …

Methods From January 2015 to December 2015, we prospectively enrolled patients with
naïve papilla who underwent ERCP at six centers. Patient-and procedure-related variables …

Background and study aims: Despite significant interest from health care authorities, patient
organizations, and insurance companies, data on procedural outcome and quality of …

Background Difficult biliary cannulation in endoscopic retrograde
cholangiopancreatography (ERCP) increases the risk of post-ERCP pancreatitis (PEP). The …

Materials and Methods In this randomized, double-blinded, prospective study, 100 patients
(49 male, 51 female), similar with regard to indication for ERCP, were enrolled between …

Background Although endoscopic retrograde cholangiopancreatography (ERCP) is a pivotal
procedure for the diagnosis and treatment of a variety of pancreatobiliary diseases, it has …